Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy
Document Type
Conference Proceeding
Publication Date
5-28-2025
Publication Title
Journal of Clinical Oncology
Abstract
2025 ASCO Annual Meeting I, May 30-June 3, 2025, Chicago, IL
Volume
43
Issue
16, Supplement
Rights
© 2024, Wolters Kluwer Health
Recommended Citation
Pusztai, Lajos; Scalise, Carly Bess; Kalashnikova, Ekaterina; Glaberman, Ursa Brown; Ehsani, Sima; Stopeck, Alison; Bhave, Manali A.; Zimmer, Alexandra Dos Santos; Torres, Evanthia T. Roussos; Klein, Paula; Sardesai, Sagar; Yan, Fengting; Sharifi, Marina Nasrin; Kabos, Peter; Razaq, Wajeeha; Loch, Michelle Marie; Rodriguez, Angel A.; and Liu, Minetta C., "Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy" (2025). School of Medicine Faculty Publications. 4132.
https://digitalscholar.lsuhsc.edu/som_facpubs/4132
10.1200/JCO.2025.43.16_suppl.1010
Comments
Abstract 1010